Anonymous
Guest
Anonymous
Guest
Only way to grow bone stims is to have a direct sales force who doesn't sell other products on the side.
A 1099 distributor rep sells too many other things that are less hassle.
If this company is serious about bone stims it will go direct like our competitor who has the largest market share.
Especially on the spine stim side. Orthopedic bone stim with all the paperwork hoops and 90 day non union is not going to take OFIX to the promise land. Time better spent in other area's. Now Spine stim being a $160mill business (approx) for Ofix needs total focus on a direct basis. Turning it over to distributors will results in regression and at the very best stagnation. Although with 70% margins it can still be a cash cow. Going distributors was a flawed strategy that will make it very difficult if not impossible to reverse the trend. The bigger issue is trying to get their arms around what is revenue and what is not. I'm amazed the stock is not in the single digits. It is a testament to Brad M and their investment relations.